UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition Xyloproct-RectalOintment-SE-AJ-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100001718-00008340, http://ema.europa.eu/fhir/eurdId
/1679
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Rectal ointment
indication:
Xyloproct rektalsalva och Xyloproct suppositorier är avsedda för behandling av vuxna. Behandling av hemorrojder, analtenesmer och analfissurer samt postoperativt efter anorektala ingrepp eller i samband med anorektala explorationer. För egenvård: hemorrojder och ytliga ändtarmsirritationer.
legalStatusOfSupply: Medicinal product not subject to medical prescription
classification: hydrocortisone
name
productName: Xyloproct Rektalsalva
part
part: Xyloproct
type: Invented Name Part
part
part: Rektalsalva
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish